In both studies, patients treated with azelastine nasal spray experienced increasing improvement inTNSS over 14 days of treatment.The improvements were approximately 2-fold greater than placebo at each day of the study, and the differences from placebo were statistically significant (P<.05) at Days 2, 7, 14, and overall.